COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

Credit: DNA- Published on January 19, 2021
Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions


BBV152

Vaccine against COVID-19
A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company..
Credit: IndiaTimes - Published 3 days ago

The phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and..
Credit: IndiaTimes - Published 3 days ago

Credit: IndiaTimes - Published 4 days ago

The trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
Credit: DNA - Published 5 days ago


Bharat Biotech

Indian biotechnology company and vaccine manufacturer
"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So..
Credit: IndiaTimes - Published 5 days ago

This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccineโ€™s co-developer, the Indian Council for Medical..
Credit: IndiaTimes - Published 5 days ago

You might like